Clinical Trial Update: Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an antioxidant strategy to improve ICSI outcomes in women with endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Antioxidant therapy

Snippet

Sponsor: Cairo University | Conditions: Endometriosis | Phase 2 | Status: COMPLETED